Success of bronchoscopically extracted small cell lung cancer (SCLC) sample in establishing primary SCLC xenografts: A preclinical aerodigestive cancer model to establish biomarker profile and response to novel therapies

被引：0
|
作者：
Yung, RC [1 ]
Watkins, DN [1 ]
Daniel, VC [1 ]
Syphard, E [1 ]
Gessel, GS [1 ]
Ames, S [1 ]
Gabrielson, E [1 ]
Flint, P [1 ]
Berman, D [1 ]
Brock, MV [1 ]
Peacock, CD [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD 21218 USA
来源：
CHEST | 2005年 / 128卷 / 04期
关键词：
D O I：
10.1378/chest.128.4_MeetingAbstracts.153S-c
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：153S / 154S
页数：2
相关论文
共 12 条
  • [1] Specific expression of OATPs in primary small cell lung cancer (SCLC) cells as novel biomarkers for diagnosis and therapy
    Brenner, Stefan
    Klameth, Lukas
    Riha, Juliane
    Schoelm, Madeleine
    Hamilton, Gerhard
    Bajna, Erika
    Ausch, Christoph
    Reiner, Angelika
    Jaeger, Walter
    Thalhammer, Theresia
    Buxhofer-Ausch, Veronika
    CANCER LETTERS, 2015, 356 (02) : 517 - 524
  • [2] Preclinical evaluation of OTX015, a novel BET-BRD inhibitor, on small cell lung cancer (SCLC) cell lines
    Ijaz, N.
    Astorgues-Xerri, L.
    Odore, E.
    Bekradda, M.
    Cvitkovic, E.
    Noel, K.
    Raymond, E.
    Riveiro, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 183 - 183
  • [3] REDEFINING VALUE IN ONCOLOGY: APPLICATION OF MIXTURE CURE MODELS FOR ECONOMIC ANALYSES OF NOVEL THERAPIES FOR SMALL CELL LUNG CANCER (SCLC)
    Roth, J.
    Yuan, Y.
    Othus, M.
    Danese, M.
    Wagner, S.
    Penrod, J. R.
    Ramsey, S. D.
    VALUE IN HEALTH, 2019, 22 : S482 - S483
  • [4] Gene expression profile of OTX015, a BET bromodomain inhibitor, in preclinical models of non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC) models
    Riveiro, Maria Eugenia
    Kwee, Ivo
    Astorgues-Xerri, Lucile
    Bekradda, Mohamed
    Vazquez, Ramiro
    Rinaldi, Andrea
    Cvitkovic, Esteban
    Bertoni, Francesco
    CANCER RESEARCH, 2015, 75
  • [5] Preclinical studies with ONC201/TIC10 and lurbinectedin as a novel combination therapy in small cell lung cancer (SCLC)
    Liguori, Nicholas R.
    Uruchurtu, Ashley Sanchez Sevilla
    Zhang, Leiqing
    Abbas, Abbas E.
    Lee, Young S.
    Zhou, Lanlan
    Azzoli, Christopher G.
    El-Deiry, Wafik S.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (02): : 729 - 743
  • [6] Novel machine learning (ML) algorithm to predict immunotherapy response in small cell (SCLC) and non-small cell (NSCLC) lung cancer
    Sharma, L.
    Choi, S.
    Balaji, V.
    Joshi, A.
    Mporas, I.
    Shi, J.
    Zhao, Y.
    Tailor, V.
    Powell, G.
    Alrifai, D.
    Shah, R.
    Waters, J. S. C.
    Adeleke, O. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S261 - S261
  • [7] Circulating tumor cells (CTC) as a biomarker of response in patients with extensive-stage small cell lung cancer (EX-SCLC).
    Huang, Chao H.
    Ganti, Apar Kishor
    Neupane, Prakash
    Sittampalam, G. Sitta
    Schmitt, Sarah
    Nirmalanandhan, Sanjit
    Williamson, Stephen K.
    Wick, Jo
    Smart, Janie
    Spencer, Sarah Ellen
    Godwin, Andrew K.
    Van Veldhuizen, Peter J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Preclinical studies with ONC201 in combination with clinically approved chemotherapy as a novel treatment strategy against Small Cell Lung Cancer (SCLC)
    Lee, Young S.
    Zhou, Lanlan
    Azzoli, Christopher
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2020, 80 (16)
  • [9] The Novel HSP90 Inhibitor-SN-38 Conjugate (STA-12-8666), Is Highly Active in Preclinical Models of Small Cell Lung Cancer (SCLC)
    Boumber, Yanis
    Gaponova, Anna
    Nikonova, Anna
    Deneka, Alexander
    Kudinov, Alexander
    Kopp, Meghan
    Egleston, Brian L.
    Litwin, Sam
    Duncan, James S.
    Duncan, Kelly
    Borghaei, Hossein
    Mehra, Ranee
    Proia, David
    Golemis, Erica
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S399 - S399
  • [10] Expansion of Phase I/II study of olaparib and temozolomide in patients with relapsed small cell lung cancer (SCLC) and co-clinical trial in patient-derived xenografts (PDXs) for biomarker discovery
    Farago, Anna F.
    Yeap, Beow
    Hung, Yin P.
    Stanzione, Marcello
    Zhong, Jun
    Phat, Sarah
    Myers, David T.
    Morris, Robert
    Kem, Marina
    Rangachari, Deepa
    Barbie, David
    Digumarthy, Subba R.
    Sequist, Lecia V.
    Hata, Aaron N.
    Mino-Kenudson, Mari
    Shaw, Alice T.
    Dyson, Nicholas
    Drapkin, Benjamin J.
    CANCER RESEARCH, 2019, 79 (13)
12